Episode Details
Back to Episodes
Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D
Season 1
Episode 15
Published 6 years, 5 months ago
Description
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.